Kyverna Therapeutics Inc.

NASDAQ: KYTX
Share price (12/23/24): $3.92
Market cap (12/23/24): $169 million

Warning: Large portions of this site require JavaScript enabled in order to function properly. Please make sure JavaScript is enabled in your browser.

Please let us know at support@bamsec.com if you have any questions or concerns.

Search in Documents

Key Exhibits

External Links

Financials Filter

ended 09/30/24 Q3

ended 06/30/24 Q2

ended 03/31/24 Q1

ended 12/31/23 FY 2023

Prospectuses and Registrations Filter

Registration of securities for employees

Registration of securities for employees

Prospectus supplement with pricing info

Initial registration of new securities – amended

Registration of securities on exchange

Ownership Filter

Westlake BioPartners Fund I, L.P.

JPMorgan Chase & Co.

Biddle Warner Weston

News Filter

Change in Directors, Officers or Compensation, Financial Statements or Exhibits

Provides Business Update and Reports Third Quarter 2024 Financial Results

Appoints Mert Aktar to Its Board of Directors

Announces Leadership Update

Provides Business Update and Reports Second Quarter 2024 Financial Results

Proxies

No filings in this category.

Other Filter

Letter from the SEC

SEC STAFF LETTER

Notice of effectiveness

Correspondence with the SEC